**Question:** Cardiac biomarker for choice of diagnosis of Reinfraction 8 days after initial ischemia is

A. Troponin
B. CK-MB
C. BNP
D. D-dimer

**Correct Answer:** D. D-dimer

**Core Concept:**

Cardiac biomarkers are proteins released from damaged cardiac cells, providing valuable information for diagnosing myocardial infarction (heart attack) and assessing its severity. In the context of the question, we are focusing on the appropriate biomarker for diagnosing reinfarction, i.e., a new myocardial infarction occurring after an initial ischemic event.

**Why the Correct Answer is Right:**

D-dimer is a specific biomarker used to rule out deep vein thrombosis (DVT) and pulmonary embolism (PE) when combined with clinical judgement and other diagnostic tests. Although D-dimer can be elevated in myocardial infarction, it is not a direct marker for myocardial damage and is not specific to cardiac events. Due to its high sensitivity but low specificity, D-dimer is not useful for diagnosing reinfarction directly.

**Why Each Wrong Option is Incorrect:**

A. Troponin (T and I): Troponin is a highly specific and sensitive biomarker for cardiac damage, including myocardial infarction. However, it is not the most suitable biomarker for diagnosing reinfarction, as it is more useful for acute events.

B. Creatine kinase-MB (CK-MB): CK-MB is a biomarker that reflects myocardial damage, including reinfarction. However, it is not specific for reinfarction and can be elevated in other cardiac conditions as well.

C. B-type natriuretic peptide (BNP): BNP is a biomarker released from the heart due to volume overload or pressure overload. While it can be elevated in reinfarction, its use in diagnosing reinfarction is limited due to its sensitivity for conditions other than myocardial infarction.

**Clinical Pearl:**

When assessing patients with suspected reinfarction, a comprehensive clinical evaluation combined with ECG changes and other cardiac biomarkers, such as troponin, is crucial for accurate diagnosis. D-dimer and CK-MB can be useful for ruling out certain conditions, but they are not specific to reinfarction.